Code | 8620D | ||||||||||
MA number | 44/0247/21-S | ||||||||||
Product Form: | tbl flm 14x1x250 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 22.10.2021 |
Validity: | 22.10.2026 |
PIL: | PIL_Abiraterón STADA 250 mg filmom obalené tablety_04.2022.pdf |
SPC: | SPC_Abiraterón STADA 250 mg filmom obalené tablety_06.2022.pdf |
Safety feature | Yes |
Data update: | 10.06.2022 |